| Identification | |
| Name: | daunomycin hydrochloride |
| Synonyms: | Daunorubicin hydrochloride; rubidomycin hydrochloride; Daunorubicin, HCl |
| CAS: | 23541-50-6 |
| EINECS: | 245-723-4 |
| Molecular Formula: | C27H29NO10?HCl |
| Molecular Weight: | 563.99 |
| InChI: | InChI=1/C27H29NO10.ClH/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33;/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3;1H/t10-,14-,16-,17-,22+,27-;/m0./s1 |
| Molecular Structure: |  |
| Properties | |
| Transport: | UN 2811 |
| Melting Point: | 188 - 190 oC |
| Density: | g/cm3 |
| Stability: | Stability |
| Appearance: | orange-red powder |
| Packinggroup: | III |
| Biological Activity: | Anticancer agent that is clinically used to treat nonlymphocytic leukaemia. Inhibits RNA and DNA synthesis and causes DNA fragmentation in vivo . |
| Usage: | Anthracycline antibiotic related to the rhodomycins. Antineoplastic |
| Safety Data | |
| Hazard Symbols |
Xn:Harmful
|
 |
|
